Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:ONC)

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

PR Newswire December 23, 2024

Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium

PR Newswire December 18, 2024

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

PR Newswire December 3, 2024

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

PR Newswire November 12, 2024

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

PR Newswire November 11, 2024

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

PR Newswire October 4, 2024

Oncolytics Biotech reports positive results from breast cancer study

Jocelyn Aspa September 19, 2024

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

PR Newswire September 19, 2024

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

PR Newswire September 6, 2024
View More News ››

Opinion & Analysis (TSX:ONC)

Buzz on the Bullboards: New Year, New Attractive Stocks

Omri Wallach January 9, 2020

Target Price Raised Ninefold on Biotech After Share Consolidation

Streetwise Reports June 6, 2018

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014
View More Opinion ››

Bullboard Posts (TSX:ONC)

RE:RE:RE:RE:RE:speaking of facts.onc chat site

Well I must say.. today was a real hoot!!
Buckhenry - 1 hour ago

RE:ASCO Jan25 ONCY Posters

The titles are both there. both also say,information will be be released to the public, 21st of this month. Additionally & as I have...
canadafan - 5 hours ago

ASCO Jan25 ONCY Posters

2 Results for "Pelareorep"Select All   ABSTRACTS & PRESENTATIONS...
Quantum41 - 6 hours ago

RE:RE:RE:RE:RE:RE:speaking of facts.onc chat site

You left out one option and that is nothing happens.  News around Christmas and we get above average volume with a spike in...
CMHarring218431 - 6 hours ago

RE:RE:RE:RE:RE:speaking of facts.onc chat site

Looks like the trading activity today . What do you believe will happen shortly . Some bet financing coming , some bet partnership , some...
spesestsemper - 7 hours ago

RE:RE:RE:RE:speaking of facts.onc chat site

Good buying opportunity... or maybe a selling opportunity... who knows??
Buckhenry - 7 hours ago
View more Bullboard ››

Prospera Energy Inc.

Prospera Energy Inc.

Prospera Energy Inc. is an energy company based in Western Canada, specializing in the exploration, development, and ...
View More »